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a  b  s  t  r  a  c  t
La  Piedad  Michoacán  Mexico  Virus  (LPMV)  is  a  member  of  the  Rubulavirus  genus  within  the Paramyx-
oviridae  family.  LPMV  is  the  etiologic  agent  of  “blue  eye  disease”,  causing  a signiﬁcant  disease  burden
in  swine  in  Mexico  with  long-term  implications  for  the  agricultural  industry.  This  virus mainly  affects
piglets  and is  characterized  by meningoencephalitis  and  respiratory  distress.  It  also  affects  adult  pigs,
causing  reduced  fertility  and  abortions  in  females,  and  orchitis  and  epididymitis  in males.
Viruses  of  the Paramyxoviridae  family  evade  the  innate  immune  response  by  targeting  components
of  the interferon  (IFN)  signaling  pathway.  The  V protein,  expressed  by  most  paramyxoviruses,  is  a  well-
characterized  IFN  signaling  antagonist.  Until  now,  there  were  no  reports  on  the  role  of the LPMV-V  protein
in inhibiting  the  IFN  response.  In  this  study  we  demonstrate  that LPMV-V  protein antagonizes  type  I butnterferon-signaling antagonist not  type  II  IFN  signaling  by binding  STAT2,  a component  of  the  type  I  IFN  cascade.  Our  results  indicate
that  the  last  18  amino  acids  of  LPMV-V  protein  are required  for binding  to STAT2  in human  and  swine
cells.  While  LPMV-V  protein  does  not  affect  the  protein  levels  of STAT1  or STAT2,  it does  prevent  the
IFN-induced  phosphorylation  and  nuclear  translocation  of  STAT1  and  STAT2  thereby  inhibiting  cellular
responses  to IFN  /.
© 2015  Elsevier  B.V.  All  rights  reserved.. Introduction
La Piedad Michoacán Mexico Virus (LPMV) is a member of
he Rubulavirus genus within the Paramyxoviridae family, in the
rder of Mononegavirales.  The virus (LPMV) was ﬁrst discovered
n swine during the early 1980s in central-west Mexico, where
∗ Corresponding author at: Department of Microbiology, Icahn School of Medicine
t  Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, United States.
ax: +1 212 534 1684.
E-mail address: adolfo.garcia-sastre@mssm.edu (A. García-Sastre.).
1 Present address: Department of Microbiology, University of Chicago, 920 East
8th Street, CLSC 711B, Chicago, IL 60637, United States.
2 Present address: Department of Microbiology, School of Medicine, University of
ashington, Rosen Building, 960 Republican St., Seattle, WA  98109-4325, United
tates.
ttp://dx.doi.org/10.1016/j.virusres.2015.10.027
168-1702/© 2015 Elsevier B.V. All rights reserved.the majority of the nation’s pig farms are located (Escobar-Lopez
et al., 2012; Moreno-Lopez et al., 1986; Stephan et al., 1988).
This swine virus is the causative agent of blue eye disease (BED)
that appears with a varied symptomatology depending on the age
of the animals. The piglets exhibit neurological and pulmonary
symptoms characterized by encephalitis, corneal opacity and/or
pneumonia (Mendoza-Magana et al., 2007; Rivera-Benitez et al.,
2013; Rodriguez-Ropon et al., 2003; Wiman et al., 1998). In adults,
the disease is characterized by symptoms that affect the repro-
ductive system. Sows exhibit increased oestrus, and an increased
incidence of stillbirth and mummiﬁed fetuses (Hernandez et al.,
1998; Hernandez-Jauregui et al., 2004). In boars, the symptomatol-
ogy is characterized by low sperm quality, orchitis and epididymitis
that can lead to permanent sterility (Cuevas-Romero et al., 2014;
Ramirez-Mendoza et al., 1997; Solis et al., 2007). BED is among
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he top four diseases that afﬂict the Mexican swine industry. The
eduction of reproductive performance and the mortality associ-
ted with LMPV infections in pigs cause signiﬁcant economic losses
Escobar-Lopez et al., 2012).
LPMV is an enveloped virus with a single-stranded negative-
ense RNA genome of approximately 15 Kb. The genome contains 6
enes encoding at least 9 proteins: the nucleoprotein (NP), matrix
M), fusion (F), hemagglutinin-neuraminidase (HN), large protein
L) and phosphoprotein (P) (Berg et al., 1997, 1991; Cuevas-Romero
t al., 2013; Linne et al., 1992; Reyes-Leyva et al., 1999; Sanchez-
etancourt et al., 2012; Sundqvist et al., 1990; Svenda et al., 1997;
enteno-Cuevas et al., 2007). The P gene of the paramyxoviruses
ncode several proteins by using different initiation codons and
y a unique mechanism involving RNA editing that generates
lternate mRNAs by site-speciﬁc co-transcriptional insertion of
on-templated nucleotides (Hausmann et al., 1999a,b; Iseni et al.,
002; Kolakofsky et al., 2005; Thomas et al., 1988). In particular the
 gene of LPMV possesses several open reading frames (ORFs). The
se of alternative initiation codons from the P gene mRNA results
n the generation of a small 126 long amino acid protein called C
s well as of P/V/W proteins LPMV V protein is 249 amino acids
n length and its ﬁrst 168 amino acids are identical to those of P
nd W proteins. Co-transcriptional editing at position correspond-
ng to amino acid 168 of V results in non template addition of one
r two G residues and in mRNAs encoding W (174 a.a.) and P (404)
roteins respectively. The C-terminal region of the LPMV V protein
LPMV-V) is 60% similar to mumps  virus V protein, 56% similar to
arainﬂuenza virus type 5 (PIV5) V protein (PIV5-V), 51% similar
o human parainﬂuenza virus type 4 V protein (hPIV4–V) and 49%
imilar to human parainﬂuenza virus type 2 V protein (hPIV2-V) at
he amino acid level (Berg et al., 1992; Sundqvist et al., 1992).
The interferon (IFN) system plays a key role in the innate
mmune defense against viral infections. In most cell types, the pro-
uction of type I IFN (IFN-/) is initiated immediately after viral
nfection leading to the subsequent activation of the IFN-/ signal-
ng cascade type I IFN signaling is activated by the binding of IFN to
ts receptors (IFNAR1 and IFNAR2) resulting in heterodimerization
f the IFNAR receptors and the resulting activation of the associ-
ted Janus kinases, Tyk2 and Jak1 (Colamonici et al., 1994, 1995)
13). The activated Janus kinases phosphorylate STAT2 (Nadeau
t al., 1999; Yan et al., 1996) on tyrosine 690 (Greenlund et al.,
995) and STAT1 (Gupta et al., 1996; Qureshi et al., 1995) on tyro-
ine 701 (Shuai et al., 1993). Phosphorylated STAT1 and STAT2
eterodimerize and associate with interferon regulatory factor 9
IRF9) to form IFN-stimulated gene factor 3 (ISGF3) (Fu et al., 1990),
hich translocate to the nucleus and binds the IFN-stimulated
esponse elements (ISREs) within interferon-stimulated gene (ISG)
romoters thereby inducing the expression of more than 100 ISGs
o establish an antiviral state that limits viral replication and dis-
emination (Childs et al., 2012; Garcia-Sastre and Biron, 2006;
arcia-Sastre et al., 1998; Laurent-Rolle et al., 2014; Manicassamy
t al., 2010; Morrison et al., 2013; Motz et al., 2013; Rajsbaum
t al., 2014; Randall and Goodbourn, 2008). Type II IFN (IFN-) is
roduced by activated immune cells (Billiau and Matthys, 2009;
eyer, 2009) and leads to the production of a different subset of
SGs via a distinct signaling pathway. Type II IFN (IFN) binds to dif-
erent receptor complex also formed of two subunits IFN-R1, and
FN-R2. Type II IFN signaling activates STAT1, by phosphorylation,
hich homodimerizes to form the interferon gamma factor (GAF),
hich translocates to the nucleus and binds to DNA at -activated
equence (GAS) elements.
Most Paramyxoviruses analyzed so far like Nipah virus, Hendrairus (Rodriguez et al., 2002, 2003), PIV5 (Didcock et al., 1999a,b;
recious et al., 2005a), hPIV2 (Parisien et al., 2001), mumps  virus
Kubota et al., 2005), canine distemper virus (CDV) (Rothlisberger
t al., 2010) with the only exception of hPIV4 (Nishio et al., 2005b),rch 213 (2016) 11–22
are able to subvert both type I and type II IFN-mediated antiviral
responses by targeting their signaling cascades.
Since Paramyxovirus IFN antagonistic activity is mainly linked
to the V proteins, we examined whether the V protein of LPMV
also had the ability to antagonize IFN signaling. In this study, we
show that LPMV-V protein evades type I IFN signaling by binding
STAT2 and preventing phosphorylation of STAT2 and STAT1. As a
result, the STAT proteins are retained in the cytoplasm, preventing
IFN-induced STATs activation and nuclear translocation, thereby
inhibiting cellular responses to IFN /. We  also show that the last
18 amino acids of LPMV-V are required for inhibiting IFN signaling.
2. Material and methods
2.1. Cells
293T, HeLa, PK13 and PK15 cells were grown in Dulbecco’s mod-
iﬁed Eagle medium (Invitrogen) supplemented with 10% fetal calf
serum (FCS), penicillin, and streptomycin. All cells were kept at
37 ◦C in the presence of 5% CO2.
2.2. Plasmids
La Piedad Michoacán Mexico Virus V open reading frame (ORF),
was ampliﬁed by reverse transcription PCR of RNA extracted from
LPMV-infected cells with MGG55 strain. Primers are available upon
request. PCR amplicons were cloned into pCAGGS (Niwa et al.,
1991) and from here on are referred to as pCAGGS-LPMV-V. A
HA-tagged version of the same amplicon was constructed by plac-
ing a hemagglutinin (HA) tag sequence encoding the amino acids
MYPYDVPDYA downstream of the V protein, from here on referred
to as pCAGGS-LPMV-V-HA. In order to determine the regions of
interaction between LPMV-V and STAT proteins, four HA-tagged
expression vectors were generated lacking the C-terminal 18, 25, 50
and 75 amino acids and from here on are referred to as V-C18-HA,
V-C25-HA, V-C50-HA, V-C75-HA respectively.
2.3. Reporter assays
293T cells (1.5 × 106) were transfected in 6-well plates with
0.5 g of a construct having an ISRE54 promoter driving the expres-
sion of a ﬁreﬂy reporter gene (pISRE54-ﬁreﬂy-luciferase), 0.1 g
of a constitutively expressing renilla luciferase reporter construct
(pCAGGS-ren-luc), and 3 g of the expression plasmids. Twenty-
four hours post-transfection, cells were washed and treated with
1000 U/ml IFN beta 1a (PBL 11410-2). Sixteen hours post-IFN treat-
ment, cells were harvested using reporter lysis buffer (Promega, cat
no E2810) and analyzed for luciferase activities normalized with
renilla activity. For IFN-dependent gene expression, a reporter
having 3 copies of the  activated sequence driving the expres-
sion of ﬁreﬂy luciferase (GAS-Luc) (0.5 g) was transfected with
0.1 g of a constitutively expressing renilla-luciferase reporter
construct (pCAGGS-ren-luc), and the indicated amounts of the
expression plasmids. Twenty-four hours post-transfection, cells
were washed and treated with IFN- (5 ng/ml) (PBL). Sixteen
hours post-IFN treatment, cells were harvested then lysed, and
the luciferase activity was  measured by applying a dual-luciferase
reporter (DLR) assay system (Promega) according to the manufac-
turer’s recommendation. The luminescence signals of the ﬁreﬂy
and the renilla luciferase were measured with a TD-20/20 Lumi-
nometer (Promega), and their ratio was called relative luciferase
activity, with the ratio over the empty vector pCAGGS set to 1
and analyzed using a DLR assay (Promega). The assays were per-
formed in triplicate and p-values were calculated by a two-tailed
Student’s t-test for unpaired samples using the software GraphPad
Prism (GraphPad Software, Inc.).
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Fig. 1. LPMV-V protein expression and cellular localization. (A) 293T cells were transfected with expression vectors for HA-tagged PIV5-V, NipahV-V or LPMV-V, and lysates
were  separated by SDS-PAGE (12% polyacrylamide). V proteins were visualized by immunoblotting with antibodies to the HA epitope tag. Western blot analysis shows
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pPMV-V-HA expression protein, with the expected molecular mass about 42 kDa. (B)
ells  were ﬁxed, permeabilized, and stained with antibodies to HA, as described in
btained using confocal microscopy.
Alternatively 293T cells were co-transfected with 3 g of
PMV-V-HA, Nipah-V-HA and PIV5-V-HA plasmids encoding the
espectively viral V proteins, 250 ng of the IFN-inducible chloram-
henicol acetyltransferase (CAT) reporter (ISG54-CAT) and 50 ng
f a plasmid constitutively expressing the ﬁreﬂy luciferase pro-
ein. 24 h post transfection cells were treated with 1000 U/ml of
uman IFN- (PBL). 24 h post treatment; cells were lysed and CAT
nd Luciferase activity were measured. A Phosphoimager was used
o quantify CAT activity and the value was normalized to ﬁreﬂy
uciferase activity. The fold induction of each sample was then cal-
ulated as the CAT activity of the IFN-treated sample normalized
o the ﬁreﬂy luciferase value of that sample. That value was  then
ivided by the normalized value of the untreated empty vector
ransfected cells.
.4. NDV-GFP bioassay
PK13 cells were transfected with either the empty pCAGGS plas-
id  or plasmids encoding various viral proteins as detailed in
peciﬁc experiments. Empty pCAGGS was used as negative con-
rol for IFN antagonism, where PIV5-V-HA protein was included as
ositive control. At 24 h post-transfection, cells were treated with cells were transfected with expression vectors for HA-tagged NipahV-V or LPMV-V.
ion 2 (materials and methods). Nuclear DNA was stained with DAPI. Images were
1000 U/ml of human IFN  (PBL). Following 24 h of IFN  treat-
ment, cells were infected with NDV-GFP as described previously
(Park et al., 2003). Fluorescence images were obtained at 14 h post-
infection. In parallel experiments, VERO cells were ﬁrst treated
with 1000 U/ml of human IFN  (PBL) for 20 h, then the cells were
transfected with either the empty pCAGGS plasmid or LPMV-V-HA
plasmid. 24 h post transfection the cells were infected with NDV-
GFP described previously (Park et al., 2003). Fluorescence images
were taken at 14 h post-infection.
2.5. Real-time PCR
293T cells where transfected with our experimental and con-
trol plasmids and 24 h later the cells where washed and treated
with 1000 U/ml IFN  or with IFN- (5 ng/ml) for an additional
12 h. Total cellular RNA was then extracted using Trizol (Invitrogen)
and cDNA was generated by reverse transcription using random
hexamers and oligo dT primers with Superscript III reverse tran-
scriptase (Invitrogen). Real-time PCRs were carried out using SYBR
green supermix (BioRad). MxA, ISG15, IP10 and IRF1 relative gene
14 G. Pisanelli et al. / Virus Research 213 (2016) 11–22
Fig. 2. LPMV-V protein inhibits type I IFN signaling but not type II IFN signaling. (A) 293T Cells were co-transfected with pCAGGS plasmids encoding NipahV-V-HA, PIV5-V-
HA  and LPMV-V-HA proteins, plus an empty vector (pCAGGS), a plasmid encoding an ISRE-54-CAT reporter and with a plasmid constitutively expressing ﬁreﬂy-luciferase
used  as control. At 24 h post transfection, cells were treated with IFN- (1000 U/ml) for 24 h prior to assaying for CAT activity. Induction of CAT activity was normalized
to  ﬁreﬂy luciferase activity. (B) 293T Cells were co-transfected with pCAGGS plasmids encoding NipahV-V, PIV5-V and LPMV-V proteins, plus an empty vector (pCAGGS),
GAS-luciferase plasmid and a plasmid driving the constitutive expression of renilla-luciferase used as internal control. 24 h post transfection the cells were treated with IFN-
(5  ng/ml) (PBL) and 24 h later cells were lysed and analyzed for GAS-luciferase activity normalized to renilla luciferase activity. (C) PK13 cells were transfected with either
the  empty pCAGGS plasmid or plasmids encoding PIV5-V-HA and LPMV-V-HA viral proteins. Empty pCAGGS was used as negative control for IFN antagonism, whereas the
PIV5-V-HA protein was  included as positive control. At 24 h post-transfection, cells were treated with 1000 U/ml of human IFN  (PBL). Following 24 h of IFN  treatment,
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Eells  were infected with NDV-GFP as described previously (Park et al., 2003). Fluo
ith  1000 U/ml of human IFN  (PBL) for 20 h, than were transfected with either t
nfected with NDV-GFP as described previously (Park et al., 2003). Fluorescence im
xpression was calculated using the comparative threshold cycle
ethod, employing 18S rRNA and GAPDH as references.
.6. Western blot
For preparation of cell extracts, 293T and PK15 cells were cul-
ured in six-well plates and transfected with our experimental and
ontrol plasmids. At 48 h post-transfection, the cells were treated
or mock treated) with 1000 U/ml IFN-  or IFN- (5 ng/ml) for
0 min  at 37 ◦C and then washed with cold PBS and incubated
n ice and subsequently lysed with 250 l of whole-cell extract
uffer (50 mM Tris [pH 8.0], 280 mM NaCl, 0.5% IGEPAL, 0.2 mM
DTA, 2 mM EGTA, 10% glycerol, 1 mM dithiothreitol [DTT]) sup-ce images were obtained at 14 h post-infection. (D). VERO cells were ﬁrst treated
pty pCAGGS plasmid or LPMV-V-HA plasmid. 24 h post transfection the cells were
ere taken at 14 h post-infection.
plemented with protease inhibitor cocktail (Complete; Boehringer
Mannheim) and sodium vanadate (0.1 mM).  Lysates were incu-
bated on ice for 10 min  and centrifuged for 10 min  at 20,000 × g
at 4 ◦C. Supernatants were analyzed on sodium dodecyl sulfate
(SDS) 4–15% polyacrylamide gels. Proteins were then transferred to
nitrocellulose membranes and were probed with antibodies against
STAT1 (Upstate Biotechnology, no. 06-501), STAT2 (Santa Cruz, no.
sc-476), phosphotyrosine 701-STAT1 (Cell Signaling Technologies,
no. 7649), Anti-phospho-STAT2 (Tyr689) (Millipore no. 07-224),
anti-actin (Sigma–Aldrich # A 5060) anti  tubulin (Cell Signal-
ing #2146) and anti-HA epitope tag (Sigma–Aldrich # H3663), and
visualized by chemiluminescence (NEN Life Sciences).
G. Pisanelli et al. / Virus Research 213 (2016) 11–22 15
Fig. 3. LPMV-V protein dampens the induction of type I interferon-stimulated genes ISG15 and MXA  but does not reduce the induction of type II interferon-stimulated genes
IP10,  IRF1. (A and B) 293T cells were transfected with our experimental and control plasmids and 24 h later the cells were washed and treated with IFN  at 1000 U/ml for an
additional 12 h. Total cellular RNA was  then extracted and cDNA was  generated by reverse transcription. Real-time PCRs were carried out using SYBR green supermix. MxA
hand  ISG15 relative gene expression was calculated using the comparative threshold cycle method, employing 18S rRNA and GAPDH as References. (C and D)  293T cells were
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.7. Co-immunoprecipitation
293T cells were seeded in 6-well plates, and the next day cells
ere transfected with LPMV-V-HA, Nipah-V-HA and PIV5-V-HA
lasmids. At 48 h postransfection, the cells were treated (or left
ntreated) with 1000 U/ml IFN-  for 30 min  at 37 ◦C and then
ashed with ice-cold phosphate-buffered saline (PBS) and subse-
uently lysed with 250 l of whole-cell extract buffer (50 mM Tris
pH 8.0], 280 mM NaCl, 0.5% IGEPAL, 0.2 mM EDTA, 2 mM EGTA, 10%
lycerol, 1 mM  dithiothreitol [DTT]) supplemented with protease
nhibitor cocktail (Complete; Boehringer Mannheim) and sodium
anadate (0.1 mM).  After a 20-min centrifugation at 20,000 × g at
◦C, aliquots for total protein analyses were separated, and the
emaining supernatants were incubated for 3 h with the Red Anti-
A afﬁnity gel antibody (Sigma–Aldrich Cat# E6779) or without
ntibody. Alternatively the supernatants were incubated for 3 h
ith the Anti-STAT2 Antibody followed by the addition of proteined and treated with IFN- (5 ng/ml) for 12 h. Total cellular RNA was then extracted
 SYBR green supermix. IP10 and IRF1 relative gene expression was calculated using
G-Sepharose beads at 4 ◦C overnight. After a 1-min centrifugation
at 5000 × g at 4 ◦C, the pellets were washed six times with whole-
cell extract buffer and ﬁnally dissolved directly in Laemmli sample
buffer for western blotting performed as described above
2.8. Indirect immunoﬂuorescence
For indirect immunoﬂuorescence experiments, HeLa cells were
grown to 70–80% conﬂuence, on cover slides in 6-well plates,
and 24 h later were transfected with empty vector, LPMV-V-
HA or NipahV-V-HA expression plasmids using lipofectamine
2000 (Invitrogen) following the manufacturer’s recommendations.
Before ﬁxation, cells were treated for 30 min  with 1000 U/ml of
IFN . At 48 h after transfection, the cells were, washed with PBS
and ﬁxed with 500 l of ice-cold methanol-acetone solution (1:1,
V/V) for 15 min. Following PBS washes cells were permeabilyzed
with 0.5% IGEPAL for 10 min  at room temperature. After 3 washes
16 G. Pisanelli et al. / Virus Research 213 (2016) 11–22
Fig. 4. LPMV-V protein inhibits type I IFN induced phosphorylation of STAT1 and STAT2 but not type II IFN-dependent phosphorylation of STAT1 and prevents STAT1 and
STAT2  nuclear translocation. (A) 293T cells were transfected with empty vector, LPMV-V-HA, NipahV-V-HA or PIV5-V-HA expression plasmids. Cells were treated for 30 min
with  1000 U/ml of IFN  prior to lysis. Lysates were separated by SDS-PAGE (12% polyacrylamide), transferred to nitrocellulose, and visualized by immunoblotting with
antisera  to STAT1, STAT2, phosphotyrosine 701-STAT1, phosphotyrosine 690-STAT2, anti-actin and anti-HA epitope tag as describe in Section 2 (materials and methods). (B)
293T  cells were transfected with empty vector, LPMV-V-HA, or PIV5-V-HA expression plasmids. Cells were treated with IFN- (5 ng/ml) per 30 min  prior to lysis. Lysates
were  separated by SDS-PAGE (12% polyacrylamide), transferred to nitrocellulose, and visualized by immunoblotting with antisera to STAT1, STAT2, phosphotyrosine 701-
STAT1,  phosphotyrosine 690-STAT2, anti-tubulin and anti-HA epitope tag as describe in Section 2 (materials and methods). (C) HeLa cells were transfected with empty
vector,  LPMV-V-HA or NipahV-V-HA expression plasmids. Before ﬁxation, cells were treated for 30 min  with 1000 U/ml of IFN . Cells were ﬁxed, permeabilized, and stained
with  antibodies against STAT1 and HA as described in Section 2 (materials and methods). (D) HeLa cells were transfected with empty vector, LPMV-V-HA or NipahV-V-HA
expression plasmids. Before ﬁxation, cells were treated for 30 min  with 1000 U/ml of IFN . Cells were ﬁxed, permeabilized, and stained with antibodies to STAT2 and HA,  as
described in Section 2 (materials and methods). Nuclear DNA was  stained with DAPI. Images were obtained using confocal microscopy.
G. Pisanelli et al. / Virus Research 213 (2016) 11–22 17
Fig. 5. LPMV-V protein interacts with human and porcine STAT2. (A and B) LPMV-V-HA, NipahV-V-Ha, PIV5-V-Ha plasmids and empty vector were transfected in 293T
cells.  At 24 h postransfection, the cells were treated (or left untreated) with 1000 U/ml IFN- for 24 h at 37 ◦C. 48 h after transfection cells were lysate. Aliquots for total
protein analyses were separated, and the remaining supernatants were incubated for 3 h with the Red Anti-HA afﬁnity gel antibody or without antibody. The pellets were
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olyacrylamide gels. Proteins were then transferred to nitrocellulose membranes
o-immunoprecipitation in 293T cells using an anti-STAT2 antibody was  performed
ith PBS, blocking of nonspeciﬁc binding sites was performed in
BG (1X PBS, 5% BSA, 0.2% ﬁsh gelatin) for 30 min  at room tem-
erature. The incubation with primary antibodies diluted in PBG
anti-STAT1 and anti-STAT2 at 1:100 dilution, and anti-HA at 1:500
ilution) was performed for 1 h at 37 ◦C. Then the slides were
ashed in PBS and incubated for 1 h at room temperature with sample buffer. The samples were analyzed on sodium dodecyl sulfate (SDS) 4–15%
ere probed with antibodies against STAT1, STAT2, HA  and Actin. (C) Reciprocal
o-immunoprecipitation assay was performed in porcine cells PK-15.
the secondary antibody diluted in PBG Alexa Fluor 555 (Invitrogen)
conjugated to mouse immunoglobulin G was used to visualize HA-
tagged V proteins, Alexa Fluor 488 (Invitrogen) conjugate to rabbit
immunoglobulin G was  used to visualize either STAT1 or STAT2.
Nuclear chromatin staining was  performed by incubation in block-
ing solution containing 0.5 mg/ml  4′,6-diamidino-2-phenylindole,
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API (Sigma–Aldrich). Cells were washed and coverslips mounted
sing Prolong antifade reagent (Invitrogen). Images were cap-
ured using a Leica SP5-DM confocal microscope at the Microscopy
hared Research Facility at Icahn School of Medicine at Mount Sinai.
. Results
.1. LPMV-V protein antagonizes IFN ˛/  ˇ but not IFN  signaling
athway
The IFN antagonist function of the V proteins of several
aramyxoviruses is well characterized. In order to evaluate the
otential of LPMV-V protein-mediated inhibition of IFN /- and
FN -mediated signaling, we ﬁrst analyzed the expression and cel-
ular localization of HA-tagged LPMV-V protein in 293T and HeLa
ells, respectively. Western blot analysis showed the expression
nd expected molecular mass of approximately 42 kDa of LPMV-V
rotein, which is closer in size to PIV5 V protein than NipahV-V pro-
ein (Fig. 1A). Indirect immunoﬂuorescence analysis revealed both
uclear and cytoplasmic localization of LPMV-V protein, and solely
ytoplasmic localization of the control protein NipahV-V (Fig. 1B).
Next we examined the effects of LPMV-V protein on type I IFN-
r type II IFN-mediated gene expression using luciferase reporter
enes under the control of IFN-responsive promoters. 293T cells
ere co-transfected with pCAGGS plasmids encoding NipahV-V,
IV5-V and LPMV-V proteins, a reporter plasmid pISRE54-CAT, a
eporter plasmid pGAS-ﬁreﬂy-luciferase and a plasmid driving the
onstitutive expression of renilla-luciferase used as internal con-
rol. Twenty-four hours post transfection the cells were treated
ith 1000 U/ml of IFN or IFN- and 24 h later cells were lysed
nd analyzed for luciferase activity. Our results show that cells
ransfected with empty plasmid and treated with IFN showed
 signiﬁcant increase in luciferase expression, as expected. The
ells expressing LPMV-V protein, showed signiﬁcantly reduced
uciferase expression driven by the ISRE promoter, which was com-
arable to that seen with the positive controls NipahV-V and PIV5-V
roteins. In contrast, LPMV-V did not reduce luciferase gene expres-
ion driven by the GAS promoter, while both NipahV-V and PIV5-V
roteins, as expected, were able to do so. (Fig. 2A and B). These
esults indicate that LPMV-V protein speciﬁcally evades type I but
ot type II IFN signaling.
To examine the biological relevance of LPMV-V protein in IFN
ntagonism, we analyzed the effect of LPMV-V on replication of
n IFN-sensitive Newcastle disease virus that expresses GFP (NDV-
FP) in the presence of type I IFN (Park et al., 2003). PK13 cells were
ransfected with plasmids encoding LMPV-V and PIV5-V proteins.
wenty-four hours post transfection, cells were either mock treated
r treated overnight with 1000 U/ml of type I IFN. The following day
he cells were infected with NDV-GFP. As expected, in cells trans-
ected with empty plasmid and treated with IFN-, NDV was unable
o replicate as evidenced by lack of GFP expression (Fig. 2C, panels
 and 2). However, in cells expressing LPMV-V protein, NDV-GFP
eplication was enhanced, similar to the positive control PIV5-V
rotein conﬁrming that LPMV-V protein blocks type I IFN medi-
ted antiviral activity (Fig. 2C, panels 3 and 4). However, when
ells were transfected with LMPV-V-HA expression plasmid 20 h
fter type I IFN treatment, LMPV-V protein was unable to rescue
DV-GFP infectivity, indicating that while LMPV-V protein inhibits
ype I IFN signaling, LMPV-V protein does not inhibit an already
stablish type I IFN-induced antiviral state (Fig. 2D).rch 213 (2016) 11–22
3.2. LPMV-V protein dampens the induction of type I
interferon-stimulated genes ISG15 and MXA.
To determine if LPMV-V protein inhibits ISG expression at the
RNA level, quantitative RT-PCR was  used to measure ISG15 and
MXA  gene expression in 293T cells that had been stimulated with
IFN  for 12 h. Results showed that the cells expressing LPMV-V pro-
tein had 25- and 325-fold lower ISG15 and MXA  transcript levels,
respectively, than cells transfected with an empty plasmid, com-
parable to the reduction showed by the control proteins NipahV-V
and PIV5-V (Fig. 3A and B).
3.3. LPMV-V protein does not reduce the induction of type II
interferon-stimulated genes IP10, IRF1
A quantitative RT-PCR was  also used to measure IP10 and IRF1
gene expression in 293T cells that had been stimulated with IFN 
for 12 h. Results showed that expression of LMPV-V protein had no
effect on IP10 and RF1 transcript levels (Fig. 3C and D).
3.4. LPMV-V reduces type I IFN-dependent phosphorylation of
STAT2 and STAT1 but not type II IFN-dependent phosphorylation
of STAT1
STAT1 and STAT2 are the targets of several Paramyxovirus V
proteins (Ramachandran and Horvath, 2009). To determine the
mechanism of LPMV-V protein inhibition of IFN signaling, we
analyzed the effect of LPMV-V protein expression on the total
levels of cellular STAT1 and STAT2 and the type I and type II
IFN-induced phosphorylation of STAT1 and STAT2. Western blot
analysis showed that the total STAT1 and STAT2 levels remained
constant in cells expressing LPMV-V protein, comparable to cells
expressing an empty plasmid. However, expression of PIV5-V
protein resulted in a loss of total STAT1, which is consistent
with published reports (Didcock et al., 1999b) (Fig. 4A and B).
Examination of LPMV-V protein effect on the type I IFN-induced
phosphorylation of STAT1 and STAT2 by western blot analysis
showed that 293T cells expressing LPMV-V protein, similarly to
those expressing NipahV-V and PIV5-V proteins, had a reduced
level of IFN-induced phosphorylation of STAT1-Y701 and STAT2-
Y690. The transfection efﬁciency (close to 90%) in this case could
explain the residual, phosho STAT1 and STAT2 activity in cells that
express LPMV-V, NipahV-V, and PIV5-V proteins. This is in contrast
to what was  observed in cells transfected with an empty vector
(Fig. 4A). The results indicate that LPMV protein had no effect on
the total cellular levels of STAT1 and STAT2 but instead inhibited
the type I IFN-activated phosphorylation of STAT1 and STAT2. Dif-
ferent results were obtained when we analyzed the role of LPMV-V
protein on the type II IFN-induced phosphorylation of STAT1. Our
data suggest that LPMV-V protein still does not inhibit efﬁciently
the induction the STAT1 phosphorylation under gamma  interferon
stimulation (Fig. 4B).
3.5. LPMV-V protein prevents type I IFN-induced STAT1 and
STAT2 nuclear translocation
Since we  had observed that the LPMV-V protein did not affect
the total level of STAT1 and STAT2 but reduced the type I IFN-
induced phosphorylation of STAT1 and STAT2, we hypothesized
that the STATs protein would be retained in the cytoplasm in
the presence of LPMV-V protein. Using confocal laser scanning
microscopy, we showed that in cells transfected with an empty
plasmid then treated with type I IFN, STAT1 and STAT2 translocate
to the nucleus. However, the IFN-induced translocation of STAT1
and STAT2 was inhibited in cells expressing LPMV-V protein similar
to the positive control NipahV-V protein (Fig. 4C and D). Thus LPMV-
G. Pisanelli et al. / Virus Research 213 (2016) 11–22 19
Fig. 6. The last 18 amino acids of LPMV-V protein are necessary for binding STAT2. (A) Alignment of V proteins from different virus in the Paramyxovirus family and schematic
representation LPMV-V-HA C-Terminal deletions mutants (V-C18-HA, V-C25-HA, V-C50-HA, V-C75-HA). (B) Co-immunoprecipitation assay of 293T cells transfected
with  LPMV-V HA deletions mutants (V-C18-HA, V-C25-HA, V-C50-HA, V-C75-HA) plasmids and empty vector were transfected in 293T cells. At 48 h postransfection,
the  cells were lysate. Aliquots for total protein analyses were separated, and the remaining supernatants were incubated for 3 h with the Red Anti-HA afﬁnity gel antibody or
without antibody. The pellets were washed six times with whole-cell extract buffer and dissolved directly in Laemmli sample buffer. The samples were analyzed on sodium
dodecyl sulfate (SDS) 4–15% polyacrylamide gels. Proteins were then transferred to nitrocellulose membranes and were probed with antibodies against STAT1, STAT2, HA and
A V, PIV
a  expr
w or ISRE
V
t
t
3
S
pctin.  (C) 293T cells were co-transfected with pCAGGS plasmids encoding NipahV-
 reporter plasmid pISRE54-ﬁreﬂy-luciferase and a plasmid driving the constitutive
ere  treated with 1000 U/ml of IFN and 24 h later cells were lysed and analyzed f
 prevents the type I IFN-induced phosphorylation and nuclear
ranslocation of STAT1 and STAT2, thus preventing formation of
he ISGF3 complex and the subsequent binding at the ISRE of ISGs.
.6. LPMV-V protein binds STAT2 proteinSince the V protein of several paramyxoviruses binds either
TAT1 and STAT2 or both, we examined whether LPMV-V
rotein has the ability to bind STAT1 and STAT2 using co-5-V and LPMV-V-Ha, V-C18-HA, V-C25-HA, V-C50-HA, V-C75-HA proteins,
ession of renilla-luciferase used as internal control. 24 h post transfection the cells
54 luciferase activity, normalized with renilla luciferase activity.
immunoprecipitation assays. 293T cells were transfected with
LPMV-V HA, NipahV-V-HA, PIV5-V HA plasmids and empty vector
HA tagged. Cell extracts were immunoprecipitated taking advan-
tage of the HA epitope, and immune complexes were processed
for immunoblotting with anti-STAT1 and anti-STAT2 antibodies.
Only STAT2 protein was  found in the LPMV-V immune complexes,
whereas NipahV-V protein, as predicted, pulled down both STAT1
and STAT2 proteins as have been previously reported (Fig. 5A).
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To rule out the possibility that low levels of STAT1 was responsi-
le for the phenotype of speciﬁc binding with STAT2, we stimulated
ells with IFN for 24 h to increase the levels of STAT1, which
s an ISG. We  then performed a co-immunoprecipitation assay
o evaluate whether LPMV-V protein would be able to precip-
tate STAT1 protein when higher levels of STAT1 are present.
he result was similar to what we observed performing the co-
mmunoprecipitation in the absence of IFN  no binding with STAT1
as detected (Fig. 5B). We  then proceeded to conﬁrm our results by
erforming a reciprocal co-immunoprecipitation. 293T cells were
ock transfected or transfected with plasmids of interest. The cell
xtracts were immunoprecipitated with STAT2 antibody, and the
mmune complexes were probed for with anti-HA antibody. The
esults conﬁrmed that STAT2 binds LPMV-V protein (Fig. 5C). Since
PMV affects pigs, we also examined whether LPMV V protein binds
orcine STAT2. Using co-immunoprecipitation assays in PK13 cells,
 cell line originated from swine, we show that LPMV-V protein
inds porcine STAT2 and not STAT1 (Fig. 5D).
In order to determine the region of LPMV-V protein that is
equired for its interaction with STAT2, we decided to focus our
ttention on the C-terminal region that has a main role for IFN
ntagonism in the Paramyxoviridae family (Ramachandran and
orvath, 2009). Four HA-tagged expression vectors were engi-
eered (Fig. 6A). One construct with a deletion of the last 18 amino
cids (V-C18-HA), a second construct with a deletion of the last
5 amino acids (V-C25-HA), a third construct with a deletion of
he last 50 amino acids (V-C50-HA) and a fourth construct with a
eletion of the last 75 amino acids (V-C75-HA) were engineered
nd tested in a co-immunoprecipitation assay in PK13 cells as in
ig. 6 panel A. The construct that had a deletion of the last 18 amino
cids did not bind STAT2 protein indicating that the C-terminus of
PMV-V protein is critical for its binding to STAT2 (Fig. 6B). Next
e analyzed the ability of the mutant proteins to inhibit the type
 IFN signaling cascade using a reporter gene assay. Our results
how that cells expressing the LPMV-V protein lacking the last 18
mino acids were unable to inhibit IFN signaling similar to mock-
ransfected cells that were treated with IFN (Fig. 6C). These results
re consistent with those obtained in the co-immunoprecipitation
xperiment with the LPMV-V proteins deletion mutant, conﬁrming
hat the last 18 amino acids are critical for the binding of LPMV-
 protein to STAT2 and for LPMV V protein type I IFN antagonist
ctivity.
. Discussion
The ability of paramyxoviruses to subvert the IFN response is
ell conserved, with the only exception being HuPIV4 (Goodbourn
nd Randall, 2009; Nishio et al., 2005b; Ramachandran and
orvath, 2009). This characteristic is due mainly to the V pro-
eins. In the Henipavirus genus, the Nipah virus and Hendra virus
 proteins, for example, inhibit IFN responses by forming high-
olecular-weight complexes with both STAT1 and STAT2 and
reventing STATs phosphorylation and translocation (Rodriguez
t al., 2002, 2003). The V protein of measles virus, of the Morbil-
ivirus genus, blocks IFN-induced STAT1 and STAT2 nuclear import
ithout degrading STATs and preventing STATs phosphorylation
Takeuchi et al., 2003). STAT polyubiquitination and proteasome-
ependent degradation is the mechanism by which the V proteins
f Rubulavirus members, like human parainﬂuenza virus 5, human
arainﬂuenza virus 2 and mumps  virus inhibit IFN signaling
Andrejeva et al., 2002; Didcock et al., 1999b; Kubota et al., 2005;
ishio et al., 2002, 2005a; Parisien et al., 2001, 2002; Ulane and
orvath, 2002) with the exception of Maupera virus that blocks
FN signaling without STATs degradation (Hagmaier et al., 2007).rch 213 (2016) 11–22
In this study we  show that LPMV-V protein evades type I inter-
feron signaling but not type II (Fig. 2A and B). A drastic reduction
of ISG15 and MXA  transcript levels was  found in cells with LPMV-
V protein expression stimulated with type I IFN, compared to the
mock-transfected cells (Fig. 3A and B) which is consistent with
published reports (Flores-Ocelotl Mdel et al., 2011). In contrast,
cells expressing LPMV-V protein, type II IFN stimulation does not
reduce IP10 and IRF1 mRNA levels (Fig. 3C and D). The biological
impact of LPMV-V protein in type I IFN antagonism was conﬁrmed
by its capacity to rescue NDV-GFP replication in the presence of
IFN (Fig. 2C panel 4). We  show that LPMV-V protein does not affect
the total level of STAT1 and STAT2, but inhibits the type I IFN-
induced phosphorylation and nuclear translocation of both STAT1
and STAT2. However, LMPV-V protein does not inhibit the type II
IFN-induced phosphorylation of STAT1 (Fig. 4A–D). Furthermore,
we show that LPMV-V protein binds selectively to STAT2 in human
and porcine cells (Fig. 5A–D) and that the last 18 amino acids of
LPMV V are required for binding STAT2. (Fig. 6B and C)
Taken together these data show that the LPMV-V protein antag-
onizes the type I IFN response but not the type II without targeting
STAT1 and STAT2 proteins for degradation. This contrasts with V
proteins from other members of the Rubulavirus genus, such as
PIV5, mumps  or HuPI2, which antagonize type I IFN signaling by
inducing degradation of the STAT1 and STAT2 proteins (Didcock
et al., 1999a,b; Kubota et al., 2005; Parisien et al., 2001, 2002;
Precious et al., 2005a,b; Ulane and Horvath, 2002). LPMV-V pro-
tein IFN evasion strategy partially resembles that of Henipavirus
V protein, with its selective binding with STAT2 protein, though
not with STAT1, and with the inhibition of STAT phosphorylation
and subsequent nuclear translocation (Rodriguez et al., 2002, 2003).
However, LPMV-V protein does not affect the type II interferon sig-
naling pathway despite its inhibition of type I interferon-mediated
STAT1 phosphorylation. The IFN signaling antagonism strategy
used by the V protein of measles, a Morbillivirus genus member,
is most similar to that used by LPMV-V protein. In fact measles
V protein inhibits type I IFN but not type II by inhibiting type I
IFN-mediated STAT1 and STAT2 phosphorylation. (Takeuchi et al.,
2003). These data suggest that by targeting STAT2, LPMV-V pro-
tein inhibits both STAT2 and STAT1 phosphorylation in response to
type I IFN signaling, resulting in inhibition of STATs protein nuclear
translocation. These data are consistent with what is described in
the literature on the primary role that STAT2 protein has in the type
I signaling activation (Leung et al., 1995; Li et al., 1997; Qureshi
et al., 1996). Similar to the strategy used by LPMV-V protein to
evade the IFN signaling cascade in the Rubulavirus genus, is the
one adopted by Maupera virus V protein. Both inhibit IFN signaling
without degrading STATs. While Maupera virus V protein inhibits
IFN signaling by binding both STAT1 and STAT2 and preventing
their nuclear translocation, without affecting their phosphoryla-
tion (Hagmaier et al., 2007), LPMV-V protein antagonizes type I
IFN signaling cascade by binding speciﬁcally to STAT2, preventing
STATs nuclear translocation and affecting their phosphorylation.
Across the Paramyxovirus family, V proteins evade the IFN sig-
naling pathway using a variety of strategies (Andrejeva et al., 2004;
Didcock et al., 1999a,b; Kubota et al., 2005; Motz et al., 2013;
Nishio et al., 2002, 2005a; Parisien et al., 2001, 2002; Precious et al.,
2005b; Rodriguez et al., 2002, 2003). Our study has found that
LPMV-V protein’s IFN signaling evasion strategy differs from the
proteasome-mediated degradation strategy that is normally used
by V proteins from members of its genus, Rubulavirus. This is despite
the fact that the C-terminal domain of LPMV-V protein is similar to
that of the other V proteins in the Rubulavirus genus and that it has
eight cysteine residues, of which seven are conserved in all V pro-
teins (Berg et al., 1992) (Fig. 5A). The similar C-terminus region of
the LPMV-V protein with the C-terminus of other paramyxovirus V
proteins is likely to be related to their essential role in interacting
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ith MDA-5, (Davis et al., 2014; Motz et al., 2013; Rodriguez and
orvath, 2014) however, the last 21 amino acids of LPMV-V protein
s unique, and this could have a key role in the IFN signaling evasion
ediated by STAT2 inactivation. This is likely the case as we found
hat the last 18 amino acids of LPMV-V are critical for STAT2 bind-
ng and type I IFN signaling inhibition. Although our results still
eed to be conﬁrmed in the context of LPMV infection, this infor-
ation could be of use in the future when designing LPMV vaccine
andidates or antiviral therapeutics against LPMV.
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